Creekmur Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$181K Sell
372
-220
-37% -$102K 0.03% 210
2025
Q2
$240K Buy
592
+183
+45% +$76.5K 0.04% 211
2025
Q1
$204K Buy
409
+386
+1,678% +$209K 0.04% 200
2024
Q4
$12K Sell
23
-4
-15% -$2.2K ﹤0.01% 404
2024
Q3
$16.7K Buy
27
+4
+17% +$2.37K ﹤0.01% 371
2024
Q2
$12.7K Sell
23
-1
-4% -$573 ﹤0.01% 459
2024
Q1
$13.9K Buy
24
+13
+118% +$7.29K ﹤0.01% 434
2023
Q4
$5.84K Buy
+11
New +$5.32K ﹤0.01% 576

Other funds holding TMO

Creekmur Asset Management's TMO Position: Q3 2025 in Review

Creekmur Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 37% in Q3 2025, selling an estimated $102K and leaving 372 shares worth $181K. The position accounts for 0.03% of the portfolio, ranked #210.

Creekmur Asset Management first reported a position in TMO in Q4 2023 and has held it in 8 quarters since. The position peaked at $240K in Q2 2025. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Creekmur Asset Management held 372 shares of Thermo Fisher Scientific worth $181K as of Q3 2025.
  • Creekmur Asset Management sold 220 Thermo Fisher Scientific shares in Q3 2025, an estimated $102K.
  • Thermo Fisher Scientific made up 0.03% of Creekmur Asset Management's portfolio in Q3 2025, its #210 holding.
  • Creekmur Asset Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 8 quarters since.
  • Creekmur Asset Management's Thermo Fisher Scientific position peaked at $240K in Q2 2025.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.